XRCC1 Arginine194Tryptophan and GGH-401Cytosine/Thymine polymorphisms are associated with response to platinum-based neoadjuvant chemotherapy in cervical cancer. [electronic resource]
Producer: 20081212Description: 509-15 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carboplatin -- administration & dosage
- Chemotherapy, Adjuvant
- Cisplatin -- administration & dosage
- DNA-Binding Proteins -- genetics
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Glutathione S-Transferase pi -- genetics
- Humans
- Interferon-gamma -- administration & dosage
- Methylenetetrahydrofolate Dehydrogenase (NADP) -- genetics
- Middle Aged
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- Polymorphism, Single Nucleotide
- Retrospective Studies
- Uterine Cervical Neoplasms -- drug therapy
- X-ray Repair Cross Complementing Protein 1
- gamma-Glutamyl Hydrolase -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.